Safety study of HDM1002 tablets on heart rhythm in healthy adults
Treatments studied
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old
- Weigh at least 50 kg (about 110 lbs) with a BMI between 19.0 and 28.0
- Be in generally good health with no major medical conditions affecting your heart, lungs, liver, kidneys, or nervous system
- Have no personal or family history of thyroid cancer or multiple endocrine neoplasia type 2 (MEN2)
- Not be pregnant or breastfeeding
- Not have had recent major surgery, blood donation, or significant blood loss in the past 3–4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the drug HDM1002 is absorbed by the body, both when taken with food and on an empty stomach. It helps researchers understand the best way to take the medication.
This study tests how a new drug (HDM1002) interacts with two other common medicines—rifampin and itraconazole—in healthy volunteers. The results will help doctors understand how to safely use the drug with other medications.
This trial tests how a new medicine, HDM1002, interacts with four common drugs (repaglinide, atorvastatin, digoxin, rosuvastatin) in healthy and overweight adults. The results will help guide safe dosing for future patients.
This study tests how a new drug called HDM1002 leaves the body, using a tiny amount of a radioactive marker. It's for healthy men, and the results will help researchers understand how the drug works.
This trial tests whether a new drug called XY0206 affects the heart's electrical activity (QTc interval). Healthy participants take either XY0206, a placebo, or a control drug to compare effects. It helps ensure the drug is safe for the heart before testing in patients.
This trial tests a medicine called HDM1002 in people who have different levels of liver function. It aims to see how the liver affects the drug and if it is safe.
Hear when a new Healthy Adult Subject trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.